Birgitte Offersen (@boffersen) 's Twitter Profile
Birgitte Offersen

@boffersen

Professor, MD, chair of DBCG, breast cancer researcher, Aarhus University Hospital, Experimental Clinical Oncology, Danish Centre for Particle Therapy.

ID: 1129388086172049408

calendar_today17-05-2019 14:07:57

115 Tweet

519 Followers

264 Following

Birgitte Offersen (@boffersen) 's Twitter Profile Photo

Landsindsamling for Kræftens Bekæmpelse i Risskov i dag. Skønt vejr og mange glade givere. Mere end 60% af beløbet går til forskning. Forhåbentlig flere kliniske studier til gavn for patienterne Kræftens Bekæmpelse

Landsindsamling for Kræftens Bekæmpelse i Risskov i dag. Skønt vejr og mange glade givere. Mere end 60% af beløbet går til forskning.
Forhåbentlig flere kliniske studier til gavn for patienterne <a href="/cancer_dk/">Kræftens Bekæmpelse</a>
Birgitte Offersen (@boffersen) 's Twitter Profile Photo

Really interesting results. We need much more focus also on the indication for breast RT, and future trials should be developed based on hypoteses from new results on biology. Trine Tramm #radonc

Birgitte Offersen (@boffersen) 's Twitter Profile Photo

The figure on the cover is from the editorial—>use the ESTRO guidelines and report your results accordingly🧐. Lift the threshold for RT details when reporting RT from clinical studies: e.g. RT technique, target def., dose/fr, doses to OAR, etc

Birgitte Offersen (@boffersen) 's Twitter Profile Photo

Helt enig👍. Lyder for godt til at være sandt, og jeg kan ikke finde Djævelen i detaljen…. Det ser ud til, at de mener det🤩🤓. Super måde at rekruttere, tillykke til dem, som får stillingerne🥂🧐

Birgitte Offersen (@boffersen) 's Twitter Profile Photo

Agree. RT is postponed for those who need it following a second breast conservation. Most likely a LR in these selected pts does not lead to distant failure. We have now randomised 600 pts in the DBCG Natural trial to +- partial breast RT. Heading for 926 pts🧐

Ane Appelt (@cancerphysicist) 's Twitter Profile Photo

I am SO excited about this!!! 🤩 We've put together a brilliant (in my humble opinion😉) line-up of speakers to discuss the challenges facing clinical re-irradiation. Please join us, it's going to be so much fun! #ReIrradiation #medphys #radonc

Birgitte Offersen (@boffersen) 's Twitter Profile Photo

Excellent. High-risk pts should be offered RNI incl IMN now. The analysis also shows gain from RNI in node-negative pts and that needs to be discussed. Looking forward🧐